Cornerstone Therapeutics' counsel leaving - Triangle Business Journal:

http://www.antonellasilipigni.com/cultura/cultura06.html
Scott Townsend’s last day with the Cary pharmaceutical company will beJune 5. Townsendd came to Cornerstone (Nasdaq: CRTX) last year from , the Massachusettx company that Cornerstone Biopharma merged with to acquire a key asthma drug and become a public company through a reverse Prior to the merger of Cornerstone and Townsend servedas Critical’s senior vice president of legal Cornerstone says it has begu n searching for a successor. Craig Cornerstone’s president and CEO, said in a statement that Townsend’w knowledge of Critical’s business was helpfu in the integration of the two But Townsend has been traveling to the Trianglre from hisMassachusetts home.
“Scotyt recognized that at this juncture inour development, we need a generaol counsel who is located full-time at our Nortg Carolina headquarters, but told us that, for familty reasons, he is currently unable to relocate from Massachusetts,” Collard said. “Thus, we mutually agreed that it would be prudenrt to make this management change atthis time.” On May 7, Cornerstone announced that Italian pharmaceutical company Chiesi Farmaceuticii SpA had in Cornerstone in a deal valued at $70 million.Cornerstoned currently retains Raleigh-based Smith, Anderson, as its externaol legal counsel.